Back to Search
Start Over
Update on Cardiovascular Safety of Incretin-Based Therapy in Adults With Type 2 Diabetes Mellitus: A Meta-Analysis of Cardiovascular Outcome Trials
- Source :
- Canadian Journal of Diabetes; 20240101, Issue: Preprints
- Publication Year :
- 2024
-
Abstract
- The authors of 2 large randomized trials have recently published their findings related to the effects of a glucagon-like peptide 1 receptor agonist (GLP-1RA) (the HARMONY trial) and a dipeptidyl peptidase 4 (DPP-4) inhibitor (the CARMELINA trial) on cardiovascular (CV) outcomes in patients with type 2 diabetes mellitus. In light of these new data, we conducted a systematic review and meta-analysis of GLP-1RAs and DPP-4 inhibitors in CV outcome trials to assess their CV safety in patients with type 2 diabetes.
Details
- Language :
- English
- ISSN :
- 14992671
- Issue :
- Preprints
- Database :
- Supplemental Index
- Journal :
- Canadian Journal of Diabetes
- Publication Type :
- Periodical
- Accession number :
- ejs50208675
- Full Text :
- https://doi.org/10.1016/j.jcjd.2019.04.003